Our Services

Physicians & Patients Reported Outcomes

Outcomes research (also often called real world evidence) is used to establish and measure the link between treatment and actual outcomes. This is achieved by measuring quality of life and satisfaction as reported by the patients but also by understanding how healthcare providers prescribe drugs and how these drugs are performing in the real world. It provides evidence-based guidance on how to improve care but also enables evaluation and generates evidence to define, substantiate, and communicate the value treatment to various stakeholders.

At Medicys, we are experts at collecting such outcomes from physicians and patients for the following types of studies

Prospective Non-Interventional studies (NIS)

Where our large network of physicians enrols patients a priori, following certain eligibility criteria and with the potential to follow them multiple times until the end of the study. The assignment of the patient to a particular therapeutic strategy falls within current practice and the prescription of the medicine is clearly separated from the decision to include the patient in the study. Each NIS seeks to measure product or intervention specific primary and secondary outcomes.
the required sample?

Case Record Forms (CRF) studies

Where Medicys recruit physicians to undertake chart reviews and completion of (usually) on-line case record forms. The number of cases reviewed can range from quite small numbers for very rare conditions to many hundreds for more common conditions.

Exit interviews

Where our expert healthcare moderators interview trial patients, usually at the last visit, or very soon after. Exit interviews are a valuable method for understanding the patient experience, informing measurement strategy and aiding interpretation of patient reported outcomes. Medicys has developed secure, tried and tested digital methods to lessen the logistical burden on investigator and sites.

Implementation science studies

Where we assist clients identify and address the barriers that slow or halt the uptake of proven health interventions and evidence based practices by recruiting and interviewing healthcare professionals and patients.

PROMs/ PREMs development and validation

We help clients who specialise in developing Patient Reported Outcomes Measures and Patient Reported Experience Measures by recruiting patients for qualitative interviews to identify statements relating to the impact of the condition on the lives of the patients and produce draft measures. We also assist in the cognitive debriefing phase by testing the measures with a fresh sample of patients before moving to the validation phase in which the measure is tested with a much larger sample of patients.

Related Work

physicians and patients reported outcomes

Therapy Area: Hematology
Topic: AML

Acute Myelogenous Leukaemia

Respondent Type: Haematologists

To understand patient characteristics, treatment patterns and real-world outcomes of Product X-treated AML patients stratified by anti-emetic prophylaxis and adherence in selected EU countries

Countries:
Sample Size: 100
Methodology: 15 minute Online Survey
Services Delivered: Recruitment, translations, scripting and hosting

physicians and patients reported outcomes

Therapy Area: Respiratory Diseases
Topic: LRTI

Lower respiratory tract infection

Respondent Type: Critical Care Medicine physicians

To understand attitudes & prescribing behaviours for patients with severe viral lower respiratory tract diseases

Countries:
Sample Size: 48 physicians and 225 PRFs
Methodology: 45 minute Web Assisted Telephone Depth Interviews, 15 minute ATU's with 25 minute Patient Record Forms
Services Delivered: Recruitment

physicians and patients reported outcomes

Therapy Area: Haematology
Topic: MM

Multiple Myeloma

Respondent Type: Haematologists

To gain an understanding and to compare treatment patterns and outcomes in Multiple Myeloma

Countries:
Sample Size: 40
Methodology: 20-minute online survey x 4 waves
Services Delivered: Recruitment

physicians and patients reported outcomes

Therapy Area: Oncology
Topic: Advanced / metastatic Renal Cell Carcinoma indication.
Respondent Type: Oncologists

To understand the treatment landscape and perception of products on the advanced / metastatic Renal Cell Carcinoma indication.

Countries:
Sample Size: 280 PRFs and 40 oncologists
Methodology: 40 minute online survey
Services Delivered: Scripting, recruitment, code frame, coding, tables

Request a quote